Antitumor activity and pharmacologic disposition of cytosine arabinoside (NSC-63878).
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use*; D004285:Dogs; D005260:Female; D008297:Male; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D051381:Rats; D014316:Tritium
D000970:Antineoplastic Agents; D003561:Cytarabine; D014316:Tritium